All lobbying filings

ARNOLD & PORTER KAYE SCHOLER LLP

Lobbying for EXELIXIS, INC. · Oncology-focused biotechnology company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $60,000.00 income · posted Jul 17, 2025

Official filing document

Bills named in this filing 2

S 1930
Small Biotech Innovation Act
HR 3731
Small Biotech Innovation Act

Lobbying activity 3

Medicare/Medicaid

Issues related to access, coverage, and payment for cancer drugs. Issues regarding the Inflation Reduction Act (Pub. L. No. 117-169), including implementation. Issues related to the Small Biotech Innovation Act (S. 1930 / H.R. 3731).

Health Issues

Issues related to access, coverage, and payment for cancer drugs. Issues regarding the 340B program. Issues related to biopharmaceutical intellectual property and patent matters.

Taxation/Internal Revenue Code

Issues related to research and development (R&D) tax credits.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.